S Sacchi, M Federico, U Vitolo, C Boccomini, D Vallisa, L Baldini, M Petrini, S Rupoli, F Di Raimondo, F Merli, V Liso, A Tabilio, G Saglio, G Vinci, M Brugiatelli, G Dastoli, GISL. Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin’s lymphoma. haematol [Internet]. 2001Sep.1 [cited 2024Nov.26];86(9):951-8. Available from: https://haematologica.org/article/view/2141